Ferdinand Massari

Ferdinand Massari is the current Chief Medical Officer at Deep Genomics. Prior to this role, Ferdinand served as President R&D at Kintai Therapeutics, a company focusing on developing therapeutics for various disease areas using proprietary chemistry. Ferdinand has also held leadership positions at companies like Shire HGT, Coley Pharmaceutical Group, Pfizer, Pharmacia, and Merck. Ferdinand's educational background includes a BA in Political Science from the University of Maryland Baltimore County, an MD from Thomas Jefferson University, and a Staff Fellow/Senior Staff Fellow in Allergy and Immunology from the National Institute of Allergy and Infectious Diseases.